Paradigm Peptides owner sentenced to 5 years 10 months for selling unapproved drugs and mislabeled testosterone
DOCUMENTED. The U.S. Attorney’s Office for the Northern District of Indiana lists the owner of Paradigm Peptides as sentenced on July 30, 2026 to 5 years 10 months in prison, and an employee to 1 year 4 months, after both pleaded guilty on Dec. 10, 2025 to selling unapproved drugs and controlled substances.
Attribution: Compiled from the U.S. Attorney’s Office, Northern District of Indiana, victim-information case page for United States v. Matthew Kawa, read on October 5, 2026. The page is short; details beyond it are not confirmed here.
Allegations in government documents and in reports by others are theirs, not findings by us. Verify against the linked sources. Disclaimer.
By Peptide Industry Gossip · Observed · Published
What happened
- The U.S. Attorney’s Office for the Northern District of Indiana lists United States v. Matthew Kawa, a case involving Paradigm Peptides (Paradigm R.E. LLC) of Michigan City, Indiana.
- Both defendants pleaded guilty on Dec. 10, 2025 to selling unapproved drugs and controlled substances, per the page, which describes testosterone misrepresented as SARMs.
- On July 30, 2026, the owner was sentenced to 5 years 10 months in prison and the employee to 1 year 4 months, each with one year of supervised release and joint restitution of $78,317.52.
- The page says the business shipped peptides, hCG and SARMs nationwide through a website, and asks customers from April 2019 through March 2024 to contact the victim-witness line.
What we can verify
- The case page lists the plea date, sentencing date, sentences, supervised release and restitution quoted above.
- The page describes the products as unapproved by FDA; it does not describe any FDA role in the case.
What remains unknown
- The exact counts of conviction and the full list of products the charges cover; the case page does not give them.
- Whether Paradigm Peptides’ website is still operating; we did not check it.
- Whether other people or related companies are under investigation.
Timeline
| Date / time | Event |
|---|---|
| 2019-04 to 2024-03 | Period for which the U.S. Attorney’s Office asks Paradigm Peptides customers to come forward. |
| 2025-12-10 | The owner and an employee plead guilty. |
| 2026-07-30 | Sentencing: owner 5 years 10 months, employee 1 year 4 months, joint restitution $78,317.52. |
Receipts
- U.S. Attorney’s Office, N.D. Indiana: United States v. Matthew Kawa (case information page) · captured 2026-10-05 · tier 1
Company response
No company response located as of the publish date.
Why people care
Most peptide enforcement so far has been FDA warning letters. This is a criminal sentence tied to a peptide-branded seller, with a mislabeling allegation (testosterone sold as SARMs) rather than a labeling-only dispute.
Corrections and update log
No corrections or updates. Request a correction.